PMC:7405836 / 114737-114887
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1010 | 42-50 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T1011 | 42-46 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T1012 | 54-62 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T1013 | 134-142 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T229 | 117-121 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T230 | 122-132 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T779 | 0-150 | Sentence | denotes | An ideal therapeutic option suggested for SARS-CoV-2 (COVID-19) is the combination therapy comprised of MAbs and the drug remdesivir (COVID-19) (201). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3123 | 42-52 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
3131 | 122-132 | Chemical | denotes | remdesivir | MESH:C000606551 |
3136 | 54-62 | Disease | denotes | COVID-19 | MESH:C000657245 |
3137 | 134-142 | Disease | denotes | COVID-19 | MESH:C000657245 |